Abbott Laboratories continues to defend itself against a patent infringement suit filed by Medinol Limited.
In its 2010 Form 10-K, Abbott reported that litigation is pending in the Regional Court in…
Hologic Inc. is defending itself against a patent suit filed by Jeffrey Schwindt.
On March 22, 2011, Jeffrey Schwindt filed suit against Hologic and its subsidiary, Suros Surgical Systems, Inc. in…
A patent infringement suit filed by Smith & Nephew Inc. against Hologic Inc. is ongoing.
On July 16, 2010 Smith & Nephew filed suit against Interlace, which the Company acquired on…
Forest Laboratories Inc. disclosed that on April 14, 2011, the trial court rendered judgment that Infosint S.A.’s UK patent is invalid.
During the quarter ended December 31, 2009, Infosint commenced comparable…
Forest Laboratories Inc. disclosed that on March 11, 2011, the Federal Circuit affirmed a ruling invalidating Infosint S.A.’s patent.
In April 2006, an action was commenced in the United States District…
A declaratory judgment action filed by Apotex Inc. against Forest Laboratories Inc. is pending.
On Jan. 10, 2011, Apotex Inc. filed a two-count declaratory judgment action against Forest and H. Lundbeck…
A trial date has yet to be set for a patent infringement suit filed by Shire plc against Watson Laboratories, Inc. relating to ADDERALL XR.
In February 2011, Shire was notified…
A patent infringement suit filed by New York University and Centocor, Inc., against Abbott Laboratories remains pending. The suit asserts that adalimumab — a drug Abbott sells under the trademark…
Patent infringement suits filed by Johnson & Johnson, Inc., Cordis Corporation, a wholly owned subsidiary of Johnson & Johnson, and Wyeth against Abbott Laboratories related to Xience V stent remain…
Abbott Laboratories’ patent infringement suit against Centocor Inc. relating to Simponi(R) is pending.
Abbott is seeking to enforce certain patent rights that cover the use of fully human anti-TNF alpha antibodies…